The research you fund through LCRF is making meaningful progress in the fight against lung cancer. Here are links to several grantees’ one-year updates, which were posted recently as a series.

Studying SETD2 in cancer cells
Francisco Expósito, PhD, Yale University
2023 LCRF Leading Edge Research Grant Program

Creating a new approach to treatment
Trever Bivona, MD, PhD, University of California, San Francisco
2023 LCRF Research Grant on Understanding Resistance in Lung Cancer

Toward effective therapies for SCLC
Benjamin Morris, PhD, MD Anderson Cancer Center
2023 LCRF Leading Edge Research Grant Program

Exploring aging and cancer growth
Luis Prieto, PhD, Mayo Clinic
2023 LCRF Minority Career Development Award (CDA) in Lung Cancer

ADCs for difficult to treat cancers
Carl Gay, MD, PhD, MD Anderson Cancer Center
2023 LCRF–Daiichi Sankyo–AstraZeneca Research Grant on Antibody Drug Conjugates

New targets for therapy-resistant SCLC
Ann Pendergast, PhD, Duke University School of Medicine
2023 LCRF Research Grant on Understanding Resistance in Lung Cancer

Inhibiting Tim-1 to enhance immunotherapy
Lloyd Bod, PhD, Massachusetts General Hospital
2023 LCRF Minority Career Development Award (CDA) in Lung Cancer